You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mucopolysaccharidosis VI

Showing 1 - 25 of 432
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI Trial in Torrance (Adalimumab Injection [Humira],

Recruiting
  • Mucopolysaccharidosis I
  • +2 more
  • Adalimumab Injection [Humira]
  • Saline Solution for Injection
  • Torrance, California
    The Lundquist Institute at Harbor-UCLA Medical Center
Aug 9, 2022

Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

Recruiting
  • Mucopolysaccharidosis I
  • +7 more
  • There is no intervention
  • San Francisco, California
    University of California San Francisco
Nov 9, 2022

MPS (RaDiCo Cohort) (RaDiCo-MPS)

Recruiting
  • Mucopolysaccharidosis I
  • +7 more
    • Angers, France
    • +22 more
    Sep 12, 2023

    Mucopolysaccharidosis Type VI Trial in Naples, Ankara (AAV2/8.TBG.hARSB)

    Active, not recruiting
    • Mucopolysaccharidosis Type VI
    • AAV2/8.TBG.hARSB
    • Naples, Italy
    • +1 more
    Nov 22, 2021

    Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy Trial in Denver, Valhalla, Salt Lake City (Human

    Completed
    • Mucopolysaccharidosis I
    • +15 more
    • Human Placental Derived Stem Cell
    • Denver, Colorado
    • +2 more
    Oct 24, 2022

    MPS IVA, MPS VI Trial in Oakland (Vosoritide Injection [Voxzogo])

    Not yet recruiting
    • MPS IVA
    • MPS VI
    • Vosoritide Injection [Voxzogo]
    • Oakland, California
      UCSF Benioff Children's Hospital Oakland
    May 4, 2023

    ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn

    Enrolling by invitation
    • Acid Sphingomyelinase Deficiency
    • +13 more
    • Confirmatory Testing
    • Bronx, New York
    • +9 more
    May 9, 2022

    Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD

    Recruiting
    • Mucopolysaccharidosis Disorders
    • +28 more
    • Stem Cell Transplantation
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 1, 2022

    Baby Detect : Genomic Newborn Screening

    Recruiting
    • Congenital Adrenal Hyperplasia
    • +126 more
      • Liege, Wallonia, Belgium
        CRMN, Hôpital La Citadelle
      Jan 24, 2023

      Mucopolysaccharidosis IV A, Mucopolysaccharidosis VI, Mucopolysaccharidoses Trial in Porto Alegre (Losartan, Placebo)

      Recruiting
      • Mucopolysaccharidosis IV A
      • +8 more
      • Porto Alegre, Rio Grande Do Sul, Brazil
        Hospital de Clinicas de Porto Alegre
      Oct 2, 2020

      Maroteaux-Lamy Syndrome Trial in Minneapolis (Naglazyme®)

      Terminated
      Has Results
      • Maroteaux-Lamy Syndrome
      • Minneapolis, Minnesota
        University of Minnesota Medical Center, Fairview
      Dec 22, 2020

      Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)

      Active, not recruiting
      • Lysosomal Storage Disease
      • +4 more
        • Cairo, Egypt
        • +4 more
        May 17, 2021

        Mucopolysaccharidosis VI Clinical Surveillance Program

        Completed
        • Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)
          • Irvine, California
          • +49 more
          Apr 2, 2021

          Mucopolysaccharidosis I, II, and VI Screening inHigh-Risk

          Terminated
          • Mucopolysaccharidosis (MPS)
            • Los Angeles, California
            • +13 more
            Mar 16, 2021

            Mucopolysaccharidosis VI Trial in Worldwide (Odiparcil, Placebo)

            Completed
            • Mucopolysaccharidosis VI
            • Bron, France
            • +3 more
            Oct 31, 2019

            Brain Structure and Function in MPS Disorders

            Completed
            • Mucopolysaccharidosis Type I
            • +4 more
              • Oakland, California
              • +3 more
              Sep 4, 2019

              Carotid Structure and Function in MPS Syndromes: A Multicenter

              Completed
              Has Results
              • Mucopolysaccharidoses
                • Orange, California
                • +1 more
                Feb 5, 2021

                Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI Trial in Minneapolis (Somatropin (DNA origin))

                Terminated
                Has Results
                • Mucopolysaccharidosis I
                • +2 more
                • Somatropin (DNA origin)
                • Minneapolis, Minnesota
                  University of Minnesota
                Aug 6, 2018

                MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))

                Recruiting
                • MPS I
                • +8 more
                • Aldurazyme (laronidase)
                • San Francisco, California
                  University of California
                Apr 21, 2022

                Mucopolysaccharidosis IH/S, Mucopolysaccharidosis IS Trial in Minneapolis (Autologous Plasmablasts (B cells))

                Not yet recruiting
                • Mucopolysaccharidosis IH/S
                • Mucopolysaccharidosis IS
                • Autologous Plasmablasts (B cells)
                • Minneapolis, Minnesota
                  University of Minnesota
                Jan 20, 2023

                Asthma Trial (FF/UMEC/VI, ELLIPTA, FF/VI)

                Not yet recruiting
                • Asthma
                • (no location specified)
                Feb 24, 2023

                Skin Laxity; Facial, Dry Skin; Facial Trial (HydraFacial Syndeo System, ReGen-GF)

                Not yet recruiting
                • Skin Laxity; Facial
                • Dry Skin; Facial
                • (no location specified)
                Jun 27, 2023

                Before and After Hematopoietic Cell Transplantation in

                Enrolling by invitation
                • Hematopoietic Cell Transplantation
                • Mucopolysaccharidosis Type I
                • Laronidase therapy and a stem cell transplant
                • Minneapolis, Minnesota
                  University of Minnesota Masonic Cancer Center
                Nov 22, 2022

                Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2 Trial in Durham (No intervention)

                Recruiting
                • Glycogen Storage Disease VI
                • +4 more
                • No intervention
                • Durham, North Carolina
                  Duke University
                Jul 27, 2022

                Mucopolysaccharidosis Type II Observational

                Withdrawn
                • Mucopolysaccharidosis II
                • Observational
                • Oakland, California
                • +2 more
                Oct 6, 2022